taxifolin has been researched along with Cardiomegaly in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, J; Gong, Y; Liu, Q; Shi, G; Yang, J; Yu, D; Zhang, Y; Zhang, Z; Zheng, Y | 1 |
Chen, Y; Cui, Y; Guo, H; Guo, Y; Shan, T; Wu, D; Xu, D; Zhang, F; Zhang, X; Zhou, H | 1 |
2 other study(ies) available for taxifolin and Cardiomegaly
Article | Year |
---|---|
Taxifolin ameliorates DEHP-induced cardiomyocyte hypertrophy via attenuating mitochondrial dysfunction and glycometabolism disorder in chicken.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Chickens; Diethylhexyl Phthalate; Mitochondria; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Quercetin; Ventricular Myosins | 2019 |
Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload.
Topics: Angiotensin-Converting Enzyme 2; Animals; Cardiomegaly; Dose-Response Relationship, Drug; Electrocardiography; Fibrosis; Mice; Myocytes, Cardiac; Oxidative Stress; Peptidyl-Dipeptidase A; Quercetin; Reactive Oxygen Species; Signal Transduction | 2015 |